Theralase Technologies, Inc. (TLT.V)
0.175
0.00 (0.00%)
CAD |
TSXV |
Oct 09, 16:00
Theralase Technologies Enterprise Value : 46.63M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 46.63M |
| October 08, 2026 | 46.63M |
| October 07, 2026 | 48.11M |
| October 06, 2026 | 46.63M |
| October 05, 2026 | 49.59M |
| October 02, 2026 | 46.63M |
| October 01, 2026 | 48.11M |
| September 30, 2026 | 48.11M |
| September 29, 2026 | 48.11M |
| September 28, 2026 | 46.63M |
| September 25, 2026 | 46.63M |
| September 24, 2026 | 46.63M |
| September 23, 2026 | 46.63M |
| September 22, 2026 | 48.11M |
| September 21, 2026 | 49.59M |
| September 18, 2026 | 49.59M |
| September 17, 2026 | 51.07M |
| September 16, 2026 | 49.59M |
| September 15, 2026 | 48.11M |
| September 14, 2026 | 48.11M |
| September 11, 2026 | 51.07M |
| September 10, 2026 | 49.59M |
| September 09, 2026 | 51.07M |
| September 08, 2026 | 51.07M |
| September 04, 2026 | 49.59M |
| Date | Value |
|---|---|
| September 03, 2026 | 48.11M |
| September 02, 2026 | 51.07M |
| September 01, 2026 | 49.59M |
| August 31, 2026 | 48.11M |
| August 28, 2026 | 49.59M |
| August 27, 2026 | 48.11M |
| August 26, 2026 | 49.59M |
| August 25, 2026 | 51.07M |
| August 24, 2026 | 51.07M |
| August 21, 2026 | 49.59M |
| August 20, 2026 | 51.07M |
| August 19, 2026 | 48.11M |
| August 18, 2026 | 48.11M |
| August 17, 2026 | 49.59M |
| August 14, 2026 | 49.59M |
| August 13, 2026 | 49.59M |
| August 12, 2026 | 46.63M |
| August 11, 2026 | 51.07M |
| August 10, 2026 | 65.85M |
| August 07, 2026 | 73.24M |
| August 06, 2026 | 71.76M |
| August 05, 2026 | 71.76M |
| August 04, 2026 | 74.72M |
| July 31, 2026 | 79.15M |
| July 30, 2026 | 77.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MedMira, Inc. | 59.28M |
| MedX Health Corp. | 25.07M |
| VentriPoint Diagnostics Ltd. | -- |
| Profound Medical Corp. | 315.29M |
| VVT Med, Inc. | 16.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.062M |
| Revenue (Quarterly) | 0.1643M |
| Total Expenses (Quarterly) | 1.226M |
| EPS Diluted (Quarterly) | -0.0037 |
| Gross Profit Margin (Quarterly) | 21.12% |
| Profit Margin (Quarterly) | -646.4% |
| Earnings Yield | -8.11% |
| Normalized Earnings Yield | -8.171 |